BioCentury
ARTICLE | Company News

Affibody, Biotest deal

July 13, 2015 7:00 AM UTC

The companies will combine Affibody’s Albumod technology, which improves the circulatory half-life of biopharmaceuticals, with undisclosed Biotest compounds. Following the research phase, Biotest will...